Sangeetha Meda Reddy, Assistant Professor
Dr. Sangeetha Reddy is a breast medical oncologist and translational immuno-oncologist focused on improving outcomes of high risk breast cancer patients by targeting the immune microenvironment and developing rational combination therapies.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Celldex TherapeuticsTopic:Investigator Initiated Clinical Trial SupportDate added:Date updated:07/26/2026Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Eli LillyTopic:Investigator Initiated Clinical Trial SupportDate added:Date updated:07/26/2026Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:BioNTechTopic:Advisory BoardDate added:07/26/2026Date updated:07/26/2026
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Daiichi SankyoTopic:Advisory BoardDate added:07/26/2026Date updated:07/26/2026Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Stemline MenariniTopic:Advisory BoardDate added:07/26/2026Date updated:07/26/2026Relationship end date:12/31/2026
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward